Latest Articles

Publication Date
Karyopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial - The Clinical Trial Vanguard

Karyopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial The Clinical Trial Vanguard

Published: Aug. 1, 2026, 6:33 a.m.
Selinexor Misses Primary Endpoint in Endometrial Cancer Trial - Medical Professionals Reference

Selinexor Misses Primary Endpoint in Endometrial Cancer Trial Medical Professionals Reference

Published: July 31, 2026, 4 a.m.
Selinexor Misses Primary Endpoint in Endometrial Cancer Trial - empr.com

Selinexor Misses Primary Endpoint in Endometrial Cancer Trial empr.com

Published: July 31, 2026, 4 a.m.
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint - TipRanks

Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint TipRanks

Published: July 30, 2026, 9:16 p.m.
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint - tipranks.com

Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint tipranks.com

Published: July 30, 2026, 9:16 p.m.
Karyopharm endometrial cancer trial misses primary endpoint By Investing.com - Investing.com Nigeria

Karyopharm endometrial cancer trial misses primary endpoint By Investing.com Investing.com Nigeria

Published: July 30, 2026, 8:42 p.m.
Karyopharm endometrial cancer trial misses primary endpoint - Investing.com

Karyopharm endometrial cancer trial misses primary endpoint Investing.com

Published: July 30, 2026, 8:31 p.m.
Alterations in Cellular Immunity in Patients With Endometriosis: Systematic Review and Meta-Analysis.

Determining the pathogenesis of endometriosis remains a major challenge in contemporary gynecology, and the investigation of alterations in cellular immunity may provide important insights into this issue. A comprehensive search …

Published: July 30, 2026, midnight
Ethanol Sclerotherapy for Primary and Recurrent Endometrioma Improves In Vitro Fertilization Pregnancy Outcomes: A Randomized Clinical Trial.

Alcohol sclerotherapy has been shown to reduce endometrioma recurrence and improve ovarian response, including the number of retrieved oocytes and antral follicle count (AFC), compared with surgical cystectomy. This randomized …

Published: July 27, 2026, midnight
Republican Primary For District 5 DALE STRONG Thiago Agustín Tirante (p0VM3wYU6j) - Mshale

Republican Primary For District 5 DALE STRONG Thiago Agustín Tirante (p0VM3wYU6j) Mshale

Published: July 18, 2026, 7:35 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!